TCL Archive AIDs Concepts Totaling $13 Million Approved By DCT Board; Will Be Funded By Special Appropriations October 11, 1985
TCL Archive Recurrent Multiple Myeloma Responds To Revimid In Phase II, Side Effects Tolerable January 31, 2003
TCL Archive M.D. Anderson, SWOG To Use Web-Based Software To Expand Access To Trials. September 29, 2000